Ovid Therapeutics Inc.OVIDNASDAQ
Loading
OVID Revenue Growth (YoY Quarterly)•+844.74%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+844.74%
+868.4pp
+786.84%
+820.4pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+15.01%
+14.8pp
+15.01%
+14.8pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -46.48% | -12.16% | +3611.24% | -23.70% | +844.74% |
| Gross Profit Growth | -46.48% | -12.16% | +3611.24% | -33.53% | +786.84% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | -154.97% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | -154.92% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | -154.92% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.46% | +0.46% | +0.27% | +0.19% | +15.01% |
| Weighted Average Shares Diluted Growth | +0.46% | +0.46% | -0.13% | +0.19% | +15.01% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -36.01% | -37.96% | -34.43% | -37.80% | +63.76% |
| Book Value per Share Growth | -22.64% | -24.63% | -37.42% | -41.52% | +66.51% |
| Debt Growth | -7.79% | -8.08% | -13.83% | -8.70% | -90.29% |
| R&D Expense Growth | -44.34% | -35.95% | -48.62% | -25.49% | +11.24% |
| SG&A Expenses Growth | +9.49% | -16.00% | -39.78% | +22.38% | -5.21% |
1 / 4